Drug recall
Vial label: Nocita (bupivacaine liposome injectable suspension), 13.3 mg/mL, [10mL or 20mL] Single use vial…
FDA recall event 97393 · Class II · ELANCO US INC
Key facts
| Event ID | 97393 |
|---|---|
| Recall numbers | V-0111-2025 |
| Recalling firm | ELANCO US INC |
| Product type | Veterinary |
| Products | Vial label: Nocita (bupivacaine liposome injectable suspension), 13.3 mg/mL, [10mL or 20mL] Single use vial, Manufactured for: Elanco US Inc., Indianapolis, IN 46221 USA. Box label: Nocita… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Temperature Abuse |
| Initiation date | Aug 11, 2025 |
| Report date | Sep 3, 2025 |
| City | Greenfield |
| State | IN |
| Country | United States |
| FEI number | 3012761605 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: